Jubilant Pharmova Limited
Quant Mutual Fund sold 11 lakh shares of Jubilant Pharmova for ₹100.65 Cr at ₹915.00 apiece in a block deal.
An integrated global pharmaceuticals company, Jubilant Pharmova operates across three core business segments: pharmaceuticals, contract research and development services, and proprietary novel drugs. The company serves domestic and international markets through its diversified portfolio and specialized capabilities in drug development and manufacturing. It combines vertically integrated operations with expertise in custom synthesis and advanced pharmaceutical formulations to address healthcare needs across multiple therapeutic areas.
Built a quantitative, data-driven investment philosophy in an industry dominated by discretionary stock pickers. Manages over Rs 1.2 lakh crore. Founded by Sanjeev Sharma, Quant MF uses VLRT (Valuation, Liquidity, Risk, and Time) framework to run high-turnover, tactically active portfolios. Grew from obscurity to one of India's top-15 AMCs in under five years, attracting both retail capital and scrutiny for its aggressive churn.